Wendell Gray Yarbrough, MD, MMHC, FACS

Professor of Surgery (Otolaryngology) and of Pathology; Section Chief, Otolaryngology; Co-Director Molecular Virology Research Program; Director, Head & Neck Cancer Program, Smilow Cancer Hospital

Clinical Interests

  • Biopsy
  • Clinical Trials as Topic
  • Head and Neck Neoplasms
  • Laryngeal Neoplasms
  • Lymphoma
  • Lymphoma, Non-Hodgkin
  • Medical Oncology
  • Mouth Neoplasms
  • Neoplasms
  • Neoplasms, Unknown Primary
  • Otolaryngology
  • Sarcoma
  • Skin Neoplasms
  • General Surgery
  • Thyroid Neoplasms
  • Tracheal Neoplasms
  • Antineoplastic Protocols
  • Early Detection of Cancer
  • Vocal Cord Dysfunction

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Child
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Head and Neck Cancer Surgery Program


Surgery: Otolaryngology: Head and Neck Cancer Services

Yale Medical Group

Clinical Trials

Conditions Study Title
Larynx, Lip, Oral Cavity and Pharynx A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 With Tremelimumab or T
Soft Tissue Individualized treatment for nasopharyngeal cancer based on the patient's DNA
Unknown Sites Novel Treatment to Enhance Smoking Cessation before Cancer Surgery
Stomach MK-3475 versus Standard Treatment in Subjects with Recurrent or Metastatic Head and Neck Cancer
Soft Tissue RTOG 3501 (TRYHARD)
Lip, Oral Cavity and Pharynx E3311: Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy w/ or w/out Chemo
Cervix Uteri Window study to assess the activity of demethylation therapy in patients with HPV positive

Edit this profile